John B. Sanfilippo & Son NASDAQ: JBSS outlined plans to expand its snack bar manufacturing business while continuing to build on its private-label nut and trail mix operations, during a presentation at the IDEAS Conference.
John B. Sanfilippo & Son remains a Buy after a Q4 earnings-driven selloff, as near-term headwinds obscure strong future growth drivers. Q4 results were impacted by high oil prices and a one-off product recall, but volume growth returned, signaling resilient demand and operational progress. I expect the upcoming bar production expansion, launching late 2026, to drive 5% annual sales growth and 7% EPS growth through the decade.
John B. Sanfilippo & Son NASDAQ: JBSS reported record fiscal 2026 net sales of $1.2 billion and a 4.6% increase in diluted earnings per share, although fourth-quarter profitability declined as higher costs, recall-related expenses and customer charges pressured margins.
Sanfilippo & Son (JBSS) came out with quarterly earnings of $0.71 per share, missing the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $1.15 per share a year ago.
John B. Sanfilippo & Son remains a "Buy" as shares are undervalued despite a 29.8% price increase since the last coverage. Q3 FY26 revenue rose 8% to $281.8 million, driven by higher selling prices, though volumes were flat and profitability declined due to increased cost of sales. Management is expanding bar production capacity and diversifying into new channels, including contract manufacturing and the pharmaceutical space.
John B. Sanfilippo & Son, Inc. is transitioning from traditional nut sales to focus on contract manufacturing and protein bar production. Despite retail sales declines from inflation, JBSS is executing a substantial capex plan to drive profitability in higher-margin sectors. The market is currently mispricing JBSS by overlooking the transformative impact of its capital investments.
John B. Sanfilippo & Son (JBSS) is evolving from a private-label nut processor to a broader snack manufacturer, with expanding bar production capabilities. JBSS delivered record sales in fiscal 2025 and Q3 FY2026, but volume growth lags, and recent margin compression reflects commodity cost pressures and pricing strategy. Operating cash flow rebounded in fiscal 2026, with capex peaking at $95 million as JBSS invests in bar capacity and production infrastructure.
Sanfilippo & Son (JBSS) came out with quarterly earnings of $1.43 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.72 per share a year ago.
John B. Sanfilippo & Son (JBSS) is executing an expansion into snack and nutrition bars, temporarily reducing free cash flow but positioning for higher future earnings. JBSS maintains a conservative balance sheet, avoids excessive leverage, and pays variable but generally generous dividends, recently declaring a $1.50 special dividend. JBSS has gradually expanded sales into the higher margin consumer channel, which comprises 82% of revenue.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
John B. Sanfilippo & Son Is A Buy After The Rally
John B. Sanfilippo & Son, Inc. (JBSS) Q2 2026 Earnings Call Transcript